Joanne Wuensch
Stock Analyst at Citi
(3.31)
# 2,444
Out of 4,676 analysts
1242
Total ratings
53.7%
Success rate
1.9%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintained: Buy | $125 | $116.13 | +7.64% | 87 | Aug 14, 2026 | |
| BDX Becton, Dickinson and Company | Maintained: Buy | $204 → $208 | $189.78 | +9.60% | 40 | Aug 14, 2026 | |
| COO The Cooper Companies | Maintained: Hold | $76 → $80 | $73.04 | +9.53% | 56 | Aug 14, 2026 | |
| DXCM DexCom | Maintained: Buy | $88 → $105 | $89.16 | +17.77% | 65 | Aug 14, 2026 | |
| SYK Stryker | Maintained: Buy | $385 → $399 | $330.59 | +20.69% | 59 | Aug 14, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Hold | $21 → $24 | $21.58 | +11.21% | 46 | Aug 14, 2026 | |
| GKOS Glaukos | Maintained: Buy | $188 → $225 | $181.39 | +24.04% | 45 | Aug 14, 2026 | |
| SGHT Sight Sciences | Maintained: Hold | $6 → $8 | $8.32 | -3.85% | 28 | Aug 14, 2026 | |
| BAX Baxter International | Maintained: Hold | $28 | $26.29 | +6.50% | 61 | Aug 13, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $61 | $49.86 | +22.34% | 78 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $90.87 | +21.05% | 81 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $92 | $108.32 | -15.07% | 29 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $150 | $143.05 | +4.86% | 45 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $16.79 | +13.16% | 30 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $500 | $371.84 | +34.47% | 36 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $298 | $273.14 | +9.10% | 63 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $91.14 | +20.69% | 83 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $99 | $100.24 | -1.24% | 63 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $123.09 | +27.55% | 58 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $92 | $72.15 | +27.51% | 22 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $17.25 | +21.74% | 18 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 | $73.91 | +1.47% | 27 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $470 | $414.44 | +13.41% | 1 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $412 | $348.48 | +18.23% | 1 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.92 | - | 5 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $92 → $96 | $125.39 | -23.44% | 19 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $350 | $324.37 | +7.90% | 43 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.15 | $2.50 | n/a | 17 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 53.72 → CHF 55.32 | CHF 58.72 | n/a | 11 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $124 → $120 | $236.59 | n/a | 23 | Jan 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $28.57 | n/a | 2 | Sep 26, 2016 |
Abbott Laboratories
Aug 14, 2026
Maintained: Buy
Price Target: $125
Current: $116.13
Upside: +7.64%
Becton, Dickinson and Company
Aug 14, 2026
Maintained: Buy
Price Target: $204 → $208
Current: $189.78
Upside: +9.60%
The Cooper Companies
Aug 14, 2026
Maintained: Hold
Price Target: $76 → $80
Current: $73.04
Upside: +9.53%
DexCom
Aug 14, 2026
Maintained: Buy
Price Target: $88 → $105
Current: $89.16
Upside: +17.77%
Stryker
Aug 14, 2026
Maintained: Buy
Price Target: $385 → $399
Current: $330.59
Upside: +20.69%
Tandem Diabetes Care
Aug 14, 2026
Maintained: Hold
Price Target: $21 → $24
Current: $21.58
Upside: +11.21%
Glaukos
Aug 14, 2026
Maintained: Buy
Price Target: $188 → $225
Current: $181.39
Upside: +24.04%
Sight Sciences
Aug 14, 2026
Maintained: Hold
Price Target: $6 → $8
Current: $8.32
Upside: -3.85%
Baxter International
Aug 13, 2026
Maintained: Hold
Price Target: $28
Current: $26.29
Upside: +6.50%
Boston Scientific
Aug 13, 2026
Maintained: Buy
Price Target: $61
Current: $49.86
Upside: +22.34%
Aug 13, 2026
Reiterated: Buy
Price Target: $110
Current: $90.87
Upside: +21.05%
Aug 13, 2026
Maintained: Hold
Price Target: $92
Current: $108.32
Upside: -15.07%
Aug 13, 2026
Maintained: Hold
Price Target: $150
Current: $143.05
Upside: +4.86%
Aug 13, 2026
Maintained: Hold
Price Target: $19
Current: $16.79
Upside: +13.16%
Aug 13, 2026
Maintained: Buy
Price Target: $500
Current: $371.84
Upside: +34.47%
Aug 13, 2026
Maintained: Buy
Price Target: $298
Current: $273.14
Upside: +9.10%
Aug 13, 2026
Reiterated: Buy
Price Target: $110
Current: $91.14
Upside: +20.69%
Aug 13, 2026
Maintained: Hold
Price Target: $99
Current: $100.24
Upside: -1.24%
Aug 13, 2026
Reiterated: Buy
Price Target: $157
Current: $123.09
Upside: +27.55%
Aug 13, 2026
Upgraded: Buy
Price Target: $92
Current: $72.15
Upside: +27.51%
Aug 13, 2026
Maintained: Buy
Price Target: $21
Current: $17.25
Upside: +21.74%
Aug 13, 2026
Maintained: Hold
Price Target: $75
Current: $73.91
Upside: +1.47%
Aug 10, 2026
Reiterated: Buy
Price Target: $470
Current: $414.44
Upside: +13.41%
Aug 3, 2026
Maintained: Buy
Price Target: $412
Current: $348.48
Upside: +18.23%
Jul 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.92
Upside: -
Jul 8, 2026
Maintained: Hold
Price Target: $92 → $96
Current: $125.39
Upside: -23.44%
Jul 8, 2026
Maintained: Hold
Price Target: $350
Current: $324.37
Upside: +7.90%
May 23, 2025
Maintained: Hold
Price Target: $4.15
Current: $2.50
Upside: n/a
Nov 16, 2022
Maintained: Hold
Price Target: CHF 53.72 → CHF 55.32
Current: CHF 58.72
Upside: n/a
Jan 27, 2019
Reiterated: Buy
Price Target: $124 → $120
Current: $236.59
Upside: n/a
Sep 26, 2016
Reiterated: Buy
Price Target: $40
Current: $28.57
Upside: n/a